Pain Management in Chronic Pancreatitis

Introduction to Pain Management

The World Journal of Emergency Surgery guidelines state that NSAIDs are acceptable first-line analgesics for chronic pancreatitis pain management, but should be avoided in acute kidney injury (AKI) 1
The 2019 WSES guidelines recommend that Non-steroidal anti-inflammatory drugs (NSAID) should be avoided in acute kidney injury (AKI) 1

The only absolute contraindication for NSAIDs in pancreatitis patients is the presence of acute kidney injury 1
Before prescribing ketorolac or mefenamic acid, verify renal function through serum creatinine and BUN levels 2
If renal impairment exists, alternative analgesics (opioids, epidural analgesia) should be considered 1
Both ketorolac and mefenamic acid are NSAIDs with similar risk profiles regarding nephrotoxicity 1
Avoid concurrent use with other nephrotoxic agents to minimize cumulative renal risk 1
Monitor for gastrointestinal side effects, particularly in patients with chronic pancreatitis who may already have compromised nutritional status 2, 3

Drotaverine, as an antispasmodic agent, has no specific contraindications mentioned in chronic pancreatitis management and can be used safely 2
Unlike NSAIDs, drotaverine does not carry nephrotoxicity concerns 1
Add drotaverine for antispasmodic effect to address cramping component 3

Check serum creatinine, BUN, and calculate GFR 1
If AKI present → avoid ketorolac and mefenamic acid entirely 1
If renal function normal → proceed to Step 2 1
Reassess pain control within 24-48 hours 1
Monitor renal function if NSAIDs continued beyond short-term use 1
If inadequate pain relief, escalate to weak opioids (tramadol) or consider epidural analgesia for severe cases 1

The most critical error is prescribing NSAIDs without checking renal function first 1
Chronic pancreatitis patients may have subclinical renal impairment due to chronic inflammation, malnutrition, or concurrent diabetes 5, 6
Undertreatment of pain leads to reduced oral intake, worsening malnutrition, and decreased quality of life 4, 2
Pain control should be aggressive enough to allow adequate nutritional intake 4
Avoid combining multiple nephrotoxic agents (NSAIDs + aminoglycosides, NSAIDs + contrast agents) 1

Effective pain management directly improves nutritional outcomes by allowing patients to tolerate the recommended 5-6 small meals daily 4, 2
Caloric intake increases after attenuation of postprandial pain 4
If NSAIDs contraindicated: consider tramadol, dilaudid (preferred over morphine in non-intubated patients), or epidural analgesia 1
Patient-controlled analgesia (PCA) should be integrated with multimodal approaches 1